Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Immunoproliferative Disorders
>>
AKT inhib
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
perifosine
(D21266) / AEterna Zentaris
7-Hydroxystaurosporine
(UCN-01) / National Cancer Institute
MK-2206
/ Merck (MSD)
afuresertib
(LAE002) / Laekna Therap
Kinenza
(enzastaurin) / Denovo, Aytu BioPharma
Estybon
(rigosertib) / Onconova, SymBio Pharma, Knight Therap
Viracept
(nelfinavir) / ViiV Healthcare, Roche
